Reaction

Malignant Urinary Tract Neoplasm reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 119 reports · 2 co-occurring drugs

As of the last recalculation, Malignant Urinary Tract Neoplasm appears in 119 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is AXITINIB (PRR 119.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Axitinib12119.7119.8
Sunitinib Malate1682.182.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.